Discover Tenders by Non Decaffeinated Coffee Sector

Find the most relevant tenders for Non Decaffeinated Coffee. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Non Decaffeinated Coffee tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Non Decaffeinated Coffee tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Open Framework Agreement On Drug Discounts In Accordance With Section 130A Paragraph 8 Of The Social Code Book V With The Option To Join At Any Time So Called Approval Model 2024 07

Deadline: 05 Jul 2026

Germany

Ref. No.: 7706731

EMD:Ref Document

Bid Value: Ref Document

187 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Naproxen M01Ae02 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7702625

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Rasagiline N04Bd02 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7697176

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Miglustat A16Ax06 As Part Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7696670

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Open Framework Agreement On Drug Discounts In Accordance With Section 130A Paragraph 8 Of The Social Code Book V With The Option To Join At Any Time So Called Approval Model 2024 08

Deadline: 05 Aug 2026

Germany

Ref. No.: 7696060

EMD:Ref Document

Bid Value: Ref Document

218 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lacosamide N03Ax18 Excluding Film Coated Tablets Within The Framework Of A So Call

Deadline: 31 Jul 2026

Germany

Ref. No.: 7693028

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Febuxostat M04Aa03 As Part Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7690242

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Irbesartan And Hydrochlorothiazide C09Da24 Within The Framework Of A So Called Open

Deadline: 31 Jul 2026

Germany

Ref. No.: 7682368

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Timolol And Latanoprost S01Ed61 Within The Framework Of A So Called Open House Mod

Deadline: 31 Jul 2026

Germany

Ref. No.: 7681822

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Silodosin G04Ca04 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7680910

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Budesonide A07Ea06 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7679307

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Glyceryl Trinitrate C01Da02 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7678980

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Second Extension Of The Contract For The Management Of The Zaintzea Municipal Service For The Care Of Non Professional Caregivers Of People At Risk Of Dependency Or In A Situation Of Dependency At The Municipal Center Located At Calle Jos Mar a Escu

Deadline: 09 Sep 2099

Spain

Ref. No.: 7678352

EMD:Ref Document

Bid Value: Ref Document

26916 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Trastuzumab L01Fd01 Only Sc Dosage Form As Part Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7677928

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Colecalciferol A11Cc05 Excluding Rx Range Within The Framework Of A So Called Open

Deadline: 31 Jul 2026

Germany

Ref. No.: 7677788

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Showing 21091 to 21105 of 21604 results

‹
1
2
...
1404
1405
1406
1407
1408
1409
1410
...
1440
1441
›

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

FREE Trial plan for all new users!